Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

What older patients get wrong about statins & aspirin | Women have lower ‘normal’ BP range than men | Metformin & COVID-19

News You Need to Know Today
What older patients get wrong about statins & aspirin | Women have lower ‘normal’ BP range than men | Metformin & COVID-19
Monday, February 22, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

What older patients are getting wrong about statins and aspirin—and how cardiologists can help

A new analysis in the Journal of the American Geriatrics Society suggests physicians could be doing more to help older patients combat cardiovascular disease. 

READ MORE >
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
Share on Twitter Share on Facebook Share on Linkedin

What older patients are getting wrong about statins and aspirin—and how cardiologists can help

Share on Twitter Share on Facebook Share on Linkedin
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
A new analysis in the Journal of the American Geriatrics Society suggests physicians could be doing more to help older patients combat cardiovascular disease. 
READ MORE >

Women have a lower ‘normal’ blood pressure range than men

Blood pressure guidelines that do not differentiate between men and women may need to be revisited.

READ MORE >
Female patient with mask
Share on Twitter Share on Facebook Share on Linkedin

Women have a lower ‘normal’ blood pressure range than men

Share on Twitter Share on Facebook Share on Linkedin
Female patient with mask
Blood pressure guidelines that do not differentiate between men and women may need to be revisited.
READ MORE >

Taking metformin for type 2 diabetes does not increase a patient’s COVID-19 risk

Yes, researchers confirmed, the popular medication is still perfectly safe to take for type 2 diabetes. 

READ MORE >
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID
Share on Twitter Share on Facebook Share on Linkedin

Taking metformin for type 2 diabetes does not increase a patient’s COVID-19 risk

Share on Twitter Share on Facebook Share on Linkedin
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID
Yes, researchers confirmed, the popular medication is still perfectly safe to take for type 2 diabetes. 
READ MORE >

Featured Articles

AI predicts new-onset AFib using 12-lead ECGs

The team's deep neural network was trained on more than 1.6 million 12-lead ECGs. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI predicts new-onset AFib using 12-lead ECGs

Share on Twitter Share on Facebook Share on Linkedin
The team's deep neural network was trained on more than 1.6 million 12-lead ECGs. 
READ MORE >

A month after discharge, heart damage still present in 54% of COVID-19 patients with raised troponin levels

“Importantly, the pattern of damage to the heart was variable, suggesting that the heart is at risk of different types of injury,” one researcher said. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

A month after discharge, heart damage still present in 54% of COVID-19 patients with raised troponin levels

Share on Twitter Share on Facebook Share on Linkedin
“Importantly, the pattern of damage to the heart was variable, suggesting that the heart is at risk of different types of injury,” one researcher said. 
READ MORE >

Intelerad Medical Systems acquires Lumedx

Intelerad Medical Systems has acquired Lumedx, an Oakland, California-based healthcare technology company focused on analytics and cardiovascular information systems. This is Intelerad’s third acquisition in the last seven months.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Intelerad Medical Systems acquires Lumedx

Share on Twitter Share on Facebook Share on Linkedin
Intelerad Medical Systems has acquired Lumedx, an Oakland, California-based healthcare technology company focused on analytics and cardiovascular information systems. This is Intelerad’s third acquisition in the last seven months.
READ MORE >

In Other News

White House taps Obama administration vet as potential first Black woman to lead CMS

Chiquita Brooks-LaSure previously served as a top health official working to implement the Affordable Care Act and aided President Biden’s team in assessing HHS during the administration switchover.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

White House taps Obama administration vet as potential first Black woman to lead CMS

Share on Twitter Share on Facebook Share on Linkedin
Chiquita Brooks-LaSure previously served as a top health official working to implement the Affordable Care Act and aided President Biden’s team in assessing HHS during the administration switchover.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million
Cardiac robotic surgery on patient 12,500 miles away | $13M for Star Trek actor HF malpractice case | New leadless pacemaker
Supreme Court sides supports cardiac drug maker | X-ray assesses pulmonary valve regurgitation | Making cardiac data actionable
Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme